Pharmacological modification of lipoprotein(a).
SmithKline Beecham Pharmaceuticals, Harlow, Essex, UK.
K
K
Suckling
D000081:Acetamides; D000085:Acetates; D000818:Animals; D000924:Anticholesteremic Agents / Q000494:pharmacology*; D002208:Caproates / Q000494:pharmacology; D002460:Cell Line; D002478:Cells, Cultured; D006801:Humans; D000960:Hypolipidemic Agents / Q000494:pharmacology*; D017270:Lipoprotein(a) / Q000097:blood / Q000235:genetics / Q000378:metabolism*; D013449:Sulfonamides; D013451:Sulfonic Acids / Q000494:pharmacology
D000081:Acetamides; D000085:Acetates; D000924:Anticholesteremic Agents; D002208:Caproates; D000960:Hypolipidemic Agents; D017270:Lipoprotein(a); D013449:Sulfonamides; D013451:Sulfonic Acids; C423185:avasimibe; C111024:gemcabene